PMK F110 Prenatal Formula
Natural health product licensed in Canada
- Other names
- Prenatal Formula
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80043698
- Status
- Active licence
- Licence date
- 17 July 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 2.6 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Vitamine C | 120 mg | 120,000 µg |
| Calcium Source : Carbonate de calcium | 200 mg | 200,000 µg |
| Thiamine Source : Mononitrate de thiamine | 1.8 mg | 1,800 µg |
| Oxyde de zinc Source : Oxyde de zinc | 25 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.6 mg | 2,600 µg |
| Folate Source : Folate | 800 microgrammes | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 30 UI | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 20 mg AT | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 20 mg | Not calculated |
Non-medicinal ingredients
Erythrosine, Dioxyde de silicium, Dioxyde de titane, Stéarate de magnésium, Croscarmellose de sodium, Talc, Acide stéarique, Poly(alcool vinylique), Cellulose microcristalline, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 day |
Uses authorised in Canada
Helps in the development and maintenance of bones and teeth. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to form red blood cells and helps in their proper function. Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80043698
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.